Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.5B | 4.9B | 4.7B | 4.8B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 116.0M | -246.8M | 118.5M | 118.2M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 22.3M | 22.6M | 22.4M | 22.8M |
Pretax income | 443.7M | 70.3M | 421.4M | 464.8M |
Tax provision | 63.5M | 24.6M | 65.1M | 60.2M |
Net income | 380.2M | 45.7M | 356.3M | 404.6M |
Basic EPS | 2.6 | — | 2.4 | 2.7 |
Diluted EPS | 2.6 | — | 2.4 | 2.7 |
Basic average shares | 150M | — | 149.7M | 149.9M |
Diluted average shares | 150M | — | 149.7M | 149.9M |
EBITDA | — | — | — | — |
Net income from continuing op. | 443.7M | 70.3M | 421.4M | 464.8M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |